查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1771560

大分子药物研发外包市场规模、份额和趋势分析报告：按工作流程、服务、治疗领域、最终用途、地区和细分市场预测，2025 年至 2030 年

Large Molecule Drug Discovery Outsourcing Market Size, Share & Trends Analysis Report By Workflow, By Service, By Therapeutics Area, By End-use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

大分子药物研发外包市场摘要

预计 2024 年全球大分子药物研发外包市场规模为 28.9 亿美元，到 2030 年将达到 48.3 亿美元，2025 年至 2030 年的复合年增长率为 9.02%。市场受到对生技药品和下一代疗法日益增长的需求的推动。

为了满足日益增长的生物製药需求，製药公司正逐渐从小分子转向更大的生物分子化合物，例如胜肽、重组蛋白和基因修饰剂。因此，药物申办方正在积极寻求专门从事此类生技药品药物研发的委外研发机构(CRO) 的服务。这种趋势导致了外包策略的兴起，这种策略强调早期科学合作以及在生物检测开发、结构生物学和功能筛检等领域的专业知识。

此外，生物製药公司与合约研究组织 (CRO) 之间的策略联盟正成为一种新兴趋势，专注于创新的平台模式，以帮助加快资产进度并降低研发风险。此外，外包服务的需求受到科学专业知识深度、成本效益和治疗领域专业化的影响。这导致与对神经退化性疾病、罕见疾病和自体免疫疾病有浓厚兴趣的合作伙伴的合作需求日益增加。

此外，随着越来越多的公司在北美和亚太等地区寻找生技药品创新中心，全球市场的扩张正在改变生物製剂市场格局。此外，合约研究组织 (CRO) 正在整合人工智慧主导的工具、生物标记发现平台和自动化筛检流程，以提高候选化合物选择的准确性。科学进步、地理成长和数位创新的结合，正在将大分子发现外包确立为现代生技药品研发策略的一个基本面向。预计这些因素将在预计期内推动市场成长。

目录

第一章调查方法与范围

第二章执行摘要

3. 大分子药物研发外包市场变数、趋势与范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 临床试验数量分析（2024年）
    • 各地区临床试验总数
    • 各阶段临床试验总数
    • 按研究设计分類的临床试验总数
    • 按主要治疗领域分類的临床试验总数
  • 定价模式分析
  • 技术格局
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章大分子药物研发外包市场：工作流程评估与趋势分析

  • 大分子药物研发外包市场（依工作流程）：细分仪表板
  • 大分子药物研发外包市场（依工作流程）：差异分析
  • 按工作流程，2018-2030
  • 目标识别与筛检
  • 目标检验和功能资讯科学
  • 潜在客户资格审查和候选人优化
  • 临床前开发
  • 其他的

第五章大分子药物研发外包市场：服务评估与趋势分析

  • 大分子药物研发外包市场（按服务）：细分仪表板
  • 大分子药物研发外包市场（按服务）：波动分析
  • 按服务分类，2018-2030 年
  • 化学服务
  • 生物服务

第六章大分子药物研发外包市场：治疗药物领域的估价与趋势分析

  • 大分子药物研发外包市场（依治疗领域）：细分仪表板
  • 大分子药物研发外包市场（依治疗领域）：波动分析
  • 依治疗领域，2018-2030年
  • 呼吸系统
  • 疼痛和麻醉
  • 肿瘤学
  • 眼科
  • 血液学
  • 心血管系统
  • 内分泌
  • 胃肠道
  • 免疫调节
  • 抗感染
  • 中枢神经系统
  • 皮肤科
  • 泌尿生殖系统

第七章大分子药物发现外包市场：最终用途估计与趋势分析

  • 大分子药物研发外包市场（依最终用途）：细分仪表板
  • 大分子药物研发外包市场（依最终用途）：差异分析
  • 按应用，2018-2030 年
  • 製药和生物技术公司
  • 学术机构

第八章大分子药物发现外包市场：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • Evotec SE
    • Charles River Laboratories International, Inc.
    • WuXi AppTec
    • Laboratory Corporation of America Holdings
    • Thermo Fisher Scientific Inc.
    • Merck &Co., Inc.
    • GenScript Biotech Corporation
    • Jubilant Biosys Limited
    • Pharmaron Beijing Co., Ltd.
    • Syngene International Limited
    • Dalton Pharma Services
    • Domainex Ltd.
    • Eurofins Scientific SE
    • QIAGEN NV
    • TCG Lifesciences Pvt Ltd.
Product Code: GVR-4-68040-616-6

Large Molecule Drug Discovery Outsourcing Market Summary

The global large molecule drug discovery outsourcing market size was estimated at USD 2.89 billion in 2024 and is projected to reach USD 4.83 billion by 2030, growing at a CAGR of 9.02% from 2025 to 2030. The market is driven by increased demand for biologics and next-generation therapies.

Pharmaceutical companies are increasingly shifting their focus from small molecules to larger biomolecules, including peptides, recombinant proteins, and gene-modifying agents, due to rising demand for biologics. As a result, drug sponsors are actively seeking the services of contract research organizations (CROs) that specialize in drug discovery tailored to these biologics. This trend has led to a rise in outsourcing strategies that emphasize early-phase scientific collaboration and expertise in areas such as bioassay development, structural biology, and functional screening.

Furthermore, emerging trends highlight strategic partnerships between biopharma companies and CROs that focus on innovative platform-based models, which serve to mitigate R&D risks while enhancing the progression of assets. In addition, the demand for outsourcing services is more influenced by the depth of scientific expertise, cost effectiveness, and specialization in therapeutic areas. This has led increasing demand for collaboration with partners who have a strong focus on neurodegenerative diseases, rare disorders, and autoimmune conditions.

Moreover, the global expansion of the market is transforming the landscape, as companies seek biologics innovation hubs in regions like North America and Asia Pacific. In addition, CROs are integrating AI-driven tools, biomarker discovery platforms, and automated screening processes to enhance the accuracy of candidate selection. This combination of scientific advancement, geographical growth, and digital innovation is establishing large molecule discovery outsourcing as a fundamental aspect of modern biologics R&D strategies. Such factors are expected to drive market growth over the estimated time period.

Global Large Molecule Drug Discovery Outsourcing Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global large molecule drug discovery outsourcing market report based on workflow, service, therapeutics area, end-use, and region:

  • Workflow Outlook (Revenue, USD Million, 2018 - 2030)
  • Target Identification & Screening
  • Target Validation & Functional Informatics
  • Lead Identification & Candidate Optimization
  • Preclinical Development
  • Others
  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemistry Services
  • Biology Services
  • Therapeutics Area Outlook (Revenue, USD Million, 2018 - 2030)
  • Respiratory system
  • Pain and Anesthesia
  • Oncology
  • Ophthalmology
  • Hematology
  • Cardiovascular
  • Endocrine
  • Gastrointestinal
  • Immunomodulation
  • Anti-infective
  • Central Nervous System
  • Dermatology
  • Genitourinary System
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical & Biotechnology companies
  • Academic Institutes
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Workflow
    • 1.2.2. Service
    • 1.2.3. Therapeutics Area
    • 1.2.4. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Large Molecule Drug Discovery Outsourcing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Clinical Trials Volume Analysis, (2024)
    • 3.3.1. Total Number Of Clinical Trials By Region
    • 3.3.2. Total Number Of Clinical Trials, By Phase
    • 3.3.3. Total Number Of Clinical Trials, By Study Design
    • 3.3.4. Total Number Of Clinical Trials, By Key Therapeutic Area
  • 3.4. Pricing Model Analysis
  • 3.5. Technology Landscape
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Force Analysis
    • 3.6.2. PESTEL by SWOT Analysis
    • 3.6.3. COVID-19 Impact Analysis

Chapter 4. Large Molecule Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis

  • 4.1. Large Molecule Drug Discovery Outsourcing Market, By Workflow: Segment Dashboard
  • 4.2. Large Molecule Drug Discovery Outsourcing Market, By Workflow: Movement Analysis
  • 4.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Workflow, 2018 - 2030 (USD Million)
  • 4.4. Target Identification & Screening
    • 4.4.1. Target Identification & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Target Validation & Functional Informatics
    • 4.5.1. Target Validation & Functional Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lead Identification & Candidate Optimization
    • 4.6.1. Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Preclinical Development
    • 4.7.1. Preclinical Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Large Molecule Drug Discovery Outsourcing Market: Service Estimates & Trend Analysis

  • 5.1. Large Molecule Drug Discovery Outsourcing Market, By Service: Segment Dashboard
  • 5.2. Large Molecule Drug Discovery Outsourcing Market, By Service: Movement Analysis
  • 5.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 5.4. Chemistry Services
    • 5.4.1. Chemistry Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biology Services
    • 5.5.1. Biology Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area Estimates & Trend Analysis

  • 6.1. Large Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Segment Dashboard
  • 6.2. Large Molecule Drug Discovery Outsourcing Market, By Therapeutics Area: Movement Analysis
  • 6.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By Therapeutics Area, 2018 - 2030 (USD Million)
  • 6.4. Respiratory system
    • 6.4.1. Respiratory System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pain and Anesthesia
    • 6.5.1. Pain and Anesthesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Oncology
    • 6.6.1. Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Ophthalmology
    • 6.7.1. Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Hematology
    • 6.8.1. Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.10. Endocrine
    • 6.10.1. Endocrine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.11. Gastrointestinal
    • 6.11.1. Gastrointestinal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.12. Immunomodulation
    • 6.12.1. Immunomodulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.13. Anti-infective
    • 6.13.1. Anti-infective Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.14. Central Nervous System
    • 6.14.1. Central Nervous System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.15. Dermatology
    • 6.15.1. Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.16. Genitourinary System
    • 6.16.1. Genitourinary System Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Large Molecule Drug Discovery Outsourcing Market: End Use Estimates & Trend Analysis

  • 7.1. Large Molecule Drug Discovery Outsourcing Market, By End Use: Segment Dashboard
  • 7.2. Large Molecule Drug Discovery Outsourcing Market, By End Use: Movement Analysis
  • 7.3. Large Molecule Drug Discovery Outsourcing Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 7.4. Pharmaceutical & Biotechnology companies
    • 7.4.1. Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Academic Institutes
    • 7.5.1. Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Large Molecule Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Dashboard
  • 8.2. Regional Market Share Analysis, 2024 & 2030
  • 8.3. North America
    • 8.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Framework
      • 8.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Framework
      • 8.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Australia
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Framework
      • 8.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Framework
      • 8.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Company Market Share/Assessment Analysis, 2024
  • 9.3. Company Profiles
    • 9.3.1. Evotec SE
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Service Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Charles River Laboratories International, Inc.
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Service Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. WuXi AppTec
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Service Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Laboratory Corporation of America Holdings
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Service Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Thermo Fisher Scientific Inc.
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Service Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Merck & Co., Inc.
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Service Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. GenScript Biotech Corporation
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Service Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Jubilant Biosys Limited
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Financial Performance
      • 9.3.8.3. Service Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. Pharmaron Beijing Co., Ltd.
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Financial Performance
      • 9.3.9.3. Service Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Syngene International Limited
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Financial Performance
      • 9.3.10.3. Service Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Dalton Pharma Services
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Financial Performance
      • 9.3.11.3. Service Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. Domainex Ltd.
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Financial Performance
      • 9.3.12.3. Service Benchmarking
      • 9.3.12.4. Strategic Initiatives
    • 9.3.13. Eurofins Scientific SE
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Financial Performance
      • 9.3.13.3. Service Benchmarking
      • 9.3.13.4. Strategic Initiatives
    • 9.3.14. QIAGEN N.V.
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Financial Performance
      • 9.3.14.3. Service Benchmarking
      • 9.3.14.4. Strategic Initiatives
    • 9.3.15. TCG Lifesciences Pvt Ltd.
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Financial Performance
      • 9.3.15.3. Service Benchmarking
      • 9.3.15.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 4. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 5. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 6. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 7. Global Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 8. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 9. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 10. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 11. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 12. North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 13. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 14. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 15. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 16. U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 17. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 18. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 19. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 20. Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 22. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 23. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 24. Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 26. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 27. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 28. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 29. Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 30. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 31. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 32. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 33. UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 34. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 35. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 37. Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 38. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 39. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 41. France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 42. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 43. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 45. Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 46. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 47. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 49. Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 50. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 51. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 52. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 53. Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 55. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 56. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 57. Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 59. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 60. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 61. Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 63. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 64. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 65. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 66. Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 68. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 69. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 70. Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 71. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 72. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 73. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 74. China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 75. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 76. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 77. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 78. India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 79. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 80. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 81. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 82. Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 83. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 84. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 85. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 86. South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 87. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 88. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 89. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 90. Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 91. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 92. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 93. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 94. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 95. Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 96. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 97. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 98. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 99. Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 100. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 101. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 102. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 103. Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 104. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 105. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 106. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 107. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 108. Middle East & Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 109. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 110. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 111. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 112. South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 113. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 114. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 115. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 116. Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 117. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 118. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 119. UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 120.UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 121. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Workflow, 2018 - 2030 (USD Million)
  • Table 122. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 123. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by Therapeutics Area, 2018 - 2030 (USD Million)
  • Table 124. Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Large Molecule Drug Discovery Outsourcing Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Large Molecule Drug Discovery Outsourcing Market: Workflow outlook and key takeaways
  • Fig. 20 Large Molecule Drug Discovery Outsourcing Market: Workflow movement analysis
  • Fig. 21 Target Identification & Screening Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Target Validation & Functional Informatics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Lead Identification & Candidate Optimization Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Preclinical Development Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Other Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Large Molecule Drug Discovery Outsourcing Market: Service outlook and key takeaways
  • Fig. 27 Large Molecule Drug Discovery Outsourcing Market: Service movement analysis
  • Fig. 28 Chemistry Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Biology Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area outlook and key takeaways
  • Fig. 31 Large Molecule Drug Discovery Outsourcing Market: Therapeutics Area movement analysis
  • Fig. 32 Respiratory system Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Pain and Anesthesia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Oncology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Ophthalmology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Hematology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Cardiovascular Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Endocrine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Gastrointestinal Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Immunomodulation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Anti-infective Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Central Nervous System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Dermatology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Genitourinary System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Large Molecule Drug Discovery Outsourcing Market: End Use outlook and key takeaways
  • Fig. 46 Large Molecule Drug Discovery Outsourcing Market: End Use movement analysis
  • Fig. 47 Pharmaceutical & Biotechnology companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Academic Institutes Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Regional Marketplace: Key Takeaways
  • Fig. 50 North America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 U.S. Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Canada Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Mexico Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Europe Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 UK Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Germany Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 France Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Italy Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Spain Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Denmark Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 Sweden Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Norway Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Japan Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 China Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 India Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Australia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Latin America Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Brazil Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 Key country dynamics
  • Fig. 91 Argentina Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 MEA Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait Large Molecule Drug Discovery Outsourcing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key company categorization
  • Fig. 102 Service heat map analysis
  • Fig. 103 Strategic framework